This person is not registered. Is this you?


Profile Details
Y Yao
Affiliations:

University of California

Institute for Physiological Chemistry
Institute of Medical Biology

Peking Union Medical College, Tsinghua University

Sichuan University, Chengdu, China

China Pharmaceutical University

Zhejiang University
Department of Respiratory Diseases

University of Michigan

Jilin University
Department of Nuclear Medicine

Xi'an Jiaotong University
Department of Hepatobiliary Surgery

Jiangsu University
Institute of Laboratory Medicine

Harbin Medical University

Shanghai Jiaotong University School of Medicine China
Department of Radiation Oncology

Dalian Medical University
Institute of Cancer Stem Cell

Cancer Hospital of Tianjin Medical University
Department of Neurology

Physikdepartment der Technischen Universität München
Department of Hematology

Unknown


 
Los Angeles, CA
Phone:
Fax:
LinkedIN:
My Blogs:
My Twitter Hashtags:
@ana_viral
 
Age:
Bio:
[1]Life Sciences Institute, University of Michigan, 210 Washtenaw Avenue, Ann Arbor, MI 48109, USA. yaoyao@umich.edu.
 
Specialty:
Cancer Biology, Cancer Immunotherapy
 
Presented at Events Covering:
, Cancer Biology, Drug Design, Translational Research
 
Areas of Interest:
 
Hobbies:
 
General Comments:
BSN Rank: 1794 / 2941 (What's this?)
Accomplish Score: 55
Popularity Score: Unavailable
# in My Circle: 0
# in My Org(s): 33622
We'll Post Your CV for Free!
 
 
Speaking/Presenting-Abstract/Poster at Mtg: 1 (13 / 0)
 
Honors and Awards: 0 (0 / 0)
 
Clinical Trial Activity: 0 (0 / 0)
 
Grant Support: 0 (0 / 0)
 
Patents Pending: 0 (0 / 0)
 
Journal - Editor/Reviewer: 0 (0 / 0)
 
Peer Reviewed Papers, Books, Chapters: 7 (42 / 0)
  • TGF-β-inducible early gene 1 (TIEG1), also known as Krüppel-like factor 10 (Klf10), represents a major downstream transcription factor of transforming growth factor-β1 (TGF-β1) signaling. ()
  • Small cell lung cancer (SCLC) is of a highly invasive and metastatic lung cancer subtype and there had not been effective targeted therapies. ()
  • Antibody-drug conjugates (ADCs) take the advantage of monoclonal antibodies to selectively deliver highly potent cytotoxic drugs to tumor cells, which have become a powerful measure for cancer treatment in recent years. ()
 
Pre/Non Reviewed Papers, Proceedings: 0 (0 / 0)
 
Membership in Professional Societies: 0 (0 / 0)
 
White Papers: 0 (0 / 0)
 
Registered on BiotechScienceNews: 0

3D Tissue Models
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.